[1]
Z. Nisa and S. Bajaj, “B3 Lesions of Breast: Two Year Retrospective Analysis of 4478 Cases Carried out in a Single Centre in the UK: B3 breast lesions”, Arch Breast Cancer, vol. 10, no. 1, pp. 81–85, Nov. 2022.